Baricitinib was approved by FDA recently for: (A) Osteo ahritis, (B) R ahritis, (C) Cl difficale, (D) Gout
Answer is B. barcitinib is a janus kinase inhibitoe JAK . Ihibits the activity of JAK 1 and JAK 2 enzymes interfering with JAK STAT pathway.